論文種別	原著(症例報告除く)
言語種別	英語
査読の有無	その他(不明)
表題	Postoperative D-dimer as a signal of venous thromboembolism in patients receiving Edoxaban after hip or knee arthroplasty.
掲載誌名	正式名：Journal of pharmaceutical health care and sciences 略　 称：J Pharm Health Care Sci ISSNコード：20550294/20550294
掲載区分	国外
巻・号・頁	11(1),pp.106
著者・共著者	Norito Nishiyama, Shiori Iwane, Masayuki Tanaka, Takanori Saito, Toshikazu Tsuji, Noboru Tanigawa
発行年月	2025/12
概要	BACKGROUND:Edoxaban is the only direct-acting oral anticoagulant (DOAC) indicated for preventing venous thromboembolism (VTE) in patients undergoing arthroplasty and can be administered for a short period (1-2 weeks). The dosage of edoxaban is set according to renal function and the presence or absence of concomitant medications with P-glycoprotein inhibitory effects. However, a small number of patients still develop VTE after lower-extremity orthopedic surgery (LE-OS), despite edoxaban administration. This single-center, exploratory cohort study retrospectively investigated patients prescribed edoxaban after LE-OS in order to explore the potential of D-dimer as a signal of VTE.METHODS:Of the 1,457 patients who received edoxaban after total hip arthroplasty or total knee arthroplasty between January 2016 and December 2020, 1,244 who cleared the exclusion criteria were divided into the non-VTE group (1,219 patients) and VTE group (25 patients). To reduce bias in VTE occurrence, patient age, sex, body weight, serum creatinine, edoxaban underdosing, previous thromboembolism, bed rest duration ≥ 48 h, and blood transfusion were matched using propensity score matching (PSM). We compared the routinely measured D-dimer values of blood samples collected on postoperative day 7 among non-VTE and VTE groups using the Mann-Whitney U test.RESULTS:After PSM, there were 23 patients in each of the non-VTE and VTE groups. The median (interquartile range) D-dimer value on postoperative day 7 was 6.2 (4.2-8.1) µg/mL in the non-VTE group and 9.6 (6.3-12.4) µg/mL in the VTE group (p = 0.005).CONCLUSIONS:This retrospective exploratory study demonstrated that D-dimer values in patients receiving edoxaban after LE-OS may serve as a signal for VTE occurrence.
DOI	10.1186/s40780-025-00513-7
PMID	41345897